Recognition of mechanisms involved in bile resistance important to halting antimicrobial resistance in nontyphoidal Salmonella.

[1]  J. Molnár,et al.  Genetic response of Salmonella enterica serotype Enteritidis to thioridazine rendering the organism resistant to the agent. , 2012, International journal of antimicrobial agents.

[2]  M. Martins,et al.  Mechanisms of Fluoroquinolone Resistance in Escherichia coli Isolates from Food-Producing Animals , 2011, Applied and Environmental Microbiology.

[3]  M. Tsai,et al.  Reappraisal of parenteral antimicrobial therapy for nontyphoidal Salmonella enteric infection in children. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[4]  J. Molnár,et al.  pH Modulation of Efflux Pump Activity of Multi-Drug Resistant Escherichia coli: Protection During Its Passage and Eventual Colonization of the Colon , 2009, PloS one.

[5]  D. Andersson,et al.  Genetic Analysis of Colistin Resistance in Salmonella enterica Serovar Typhimurium , 2009, Antimicrobial Agents and Chemotherapy.

[6]  Clinical,et al.  Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement , 2008 .

[7]  Clinical,et al.  Performance standards for antimicrobial disk susceptibility tests : approved standard , 2006 .

[8]  C. Hill,et al.  The interaction between bacteria and bile. , 2005, FEMS microbiology reviews.

[9]  J. Pagés,et al.  Inhibitors of efflux pumps in Gram-negative bacteria. , 2005, Trends in molecular medicine.

[10]  C. Chiu,et al.  Increasing ceftriaxone resistance in Salmonella isolates from a university hospital in Taiwan. , 2005, The Journal of antimicrobial chemotherapy.

[11]  C. Chiu,et al.  Antimicrobial resistance in nontyphoid Salmonella serotypes: a global challenge. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  C. Chiu,et al.  Isolation of Salmonella enterica serotype choleraesuis resistant to ceftriaxone and ciprofloxacin , 2004, The Lancet.

[13]  J. Wu,et al.  Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from Pigs to Humans, Taiwan , 2004, Emerging infectious diseases.

[14]  J. Casadesús,et al.  Envelope instability in DNA adenine methylase mutants of Salmonella enterica. , 2002, Microbiology.

[15]  C. Chiu,et al.  EMERGENCE OF FLUOROQUINOLONE RESISTANCE IN SALMONELLA ENTERICA SEROTYPE CHOLERAESUIS THE EMERGENCE IN TAIWAN OF FLUOROQUINOLONE RESISTANCE IN SALMONELLA ENTERICA SEROTYPE CHOLERAESUIS , 2002 .

[16]  A. Cloeckaert,et al.  Mechanisms of quinolone resistance in Salmonella. , 2001, Veterinary research.

[17]  S. Levy,et al.  Genetic Characterization of Highly Fluoroquinolone-Resistant Clinical Escherichia coli Strains from China: Role ofacrR Mutations , 2001, Antimicrobial Agents and Chemotherapy.

[18]  S. Miller,et al.  Salmonella enterica Serovar TyphimuriumwaaP Mutants Show Increased Susceptibility to Polymyxin and Loss of Virulence In Vivo , 2000, Infection and Immunity.

[19]  J. Gunn.  Mechanisms of bacterial resistance and response to bile. , 2000, Microbes and infection.

[20]  E. Giraud,et al.  Evidence for Active Efflux as the Primary Mechanism of Resistance to Ciprofloxacin in Salmonella enterica Serovar Typhimurium , 2000, Antimicrobial Agents and Chemotherapy.

[21]  T. Renau,et al.  Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. , 1999, Journal of medicinal chemistry.

[22]  A. Thakkinstian,et al.  Clinical and prognostic categorization of extraintestinal nontyphoidal Salmonella infections in infants and children. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  J. Casadesús,et al.  DNA adenine methylase mutants of Salmonella typhimurium show defects in protein secretion, cell invasion, and M cell cytotoxicity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Gunn,et al.  PhoP-PhoQ-Regulated Loci Are Required for Enhanced Bile Resistance in Salmonella spp , 1999, Infection and Immunity.

[25]  S. Miller,et al.  PmrA–PmrB‐regulated genes necessary for 4‐aminoarabinose lipid A modification and polymyxin resistance , 1998, Molecular microbiology.

[26]  L. Piddock,et al.  Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals , 1996, Antimicrobial agents and chemotherapy.

[27]  H. Nikaido,et al.  AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants , 1996, Journal of bacteriology.

[28]  J. J. Farmer.  Enterobacteriaceae : introduction and identification , 1995 .

[29]  Henry Nider,et al.  Report of the Committee on Infectious Diseases , 1989 .

[30]  M. Blaser,et al.  A review of human salmonellosis: II. Duration of excretion following infection with nontyphi Salmonella. , 1984, Reviews of infectious diseases.

[31]  R. Jones,et al.  Evaluation of the sensititre microdilution antibiotic susceptibility system against recent clinical isolates: three-laboratory collaborative study , 1980, Journal of clinical microbiology.

[32]  Ellen Jo Baron,et al.  Manual of clinical microbiology , 1975 .